Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

globenewswire.com
ANAB AnaptysBio is participating in a virtual conference, which is a standard corporate event. The article does not provide any new financial information or outlook that would suggest a bullish or bearish sentiment.

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga, president and chief executive officer of Anaptys, is scheduled to participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 1:30pm ET.

To register for the conference, please visit https://hcwevents.com/royalty-company-conference.

About Anaptys

Anaptys manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.

Contact:

Anaptys Investor Relations

investors@anaptysbio.com